Shares Outstanding Shares Outstanding n/a Close	7.36M
Shares Change (YoY) Shares Change (YoY) n/a Close	2964.8%
Shares Change (QoQ) Shares Change (QoQ) n/a Close	14.77%
Owned by Institutions (%) Owned by Institutions (%) n/a Close	6.48%
Shares Floating Shares Floating n/a Close	7.35M
Failed to Deliver (FTD) Shares Failed to Deliver (FTD) Shares n/a Close	693
FTD / Avg. Volume FTD / Avg. Volume n/a Close	0.07%

Short Selling Information

The latest short interest is 1.06M, so 14.42% of the outstanding shares have been sold short.

Short Interest Short Interest n/a Close	1.06M
Short % of Shares Out Short % of Shares Out n/a Close	14.42%
Short % of Float Short % of Float n/a Close	14.42%
Short Ratio (days to cover) Short Ratio (days to cover) n/a Close	1

Valuation Ratios

The PE ratio is -0.57 and the forward PE ratio is -5.6. Tonix Pharmaceuticals's PEG ratio is 0.01.

PE Ratio PE Ratio n/a Close	-0.57
Forward PE Forward PE n/a Close	-5.6
PS Ratio PS Ratio n/a Close	7.4
Forward PS Forward PS n/a Close	0.4
PB Ratio PB Ratio n/a Close	0.53
P/FCF Ratio P/FCF Ratio n/a Close	-1.22
PEG Ratio PEG Ratio n/a Close	0.01

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Tonix Pharmaceuticals.

EV / Sales EV / Sales n/a Close	n/a
EV / EBITDA EV / EBITDA n/a Close	n/a
EV / EBIT EV / EBIT n/a Close	n/a
EV / FCF EV / FCF n/a Close	n/a

Financial Position

The company has a current ratio of 6.5, with a Debt / Equity ratio of 0.06.

Current Ratio Current Ratio n/a Close	6.5
Quick Ratio Quick Ratio n/a Close	6.04
Debt / Equity Debt / Equity n/a Close	0.06
Debt / EBITDA Debt / EBITDA n/a Close	-0.11
Debt / FCF Debt / FCF n/a Close	-0.13
Interest Coverage Interest Coverage n/a Close	0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity Return on Equity n/a Close	n/a
Return on Assets Return on Assets n/a Close	n/a
Return on Invested Capital Return on Invested Capital n/a Close	n/a
Revenue Per Employee Revenue Per Employee n/a Close	$124,617.28
Profits Per Employee Profits Per Employee n/a Close	$-1,605,382.72
Employee Count Employee Count n/a Close	81
Asset Turnover Asset Turnover n/a Close	0.06
Inventory Turnover Inventory Turnover n/a Close	0.92

Taxes

Income Tax Income Tax n/a Close	-1.17M
Effective Tax Rate Effective Tax Rate n/a Close	0.9%

Stock Price Statistics

The stock price has increased by -48.59% in the last 52 weeks. The beta is 2.1, so Tonix Pharmaceuticals's price volatility has been higher than the market average.

Beta Beta n/a Close	2.1
52-Week Price Change 52-Week Price Change n/a Close	-48.59%
50-Day Moving Average 50-Day Moving Average n/a Close	27.6
200-Day Moving Average 200-Day Moving Average n/a Close	21.68
Relative Strength Index (RSI) Relative Strength Index (RSI) n/a Close	54.61
Average Volume (20 Days) Average Volume (20 Days) n/a Close	970,187

Income Statement

In the last 12 months, Tonix Pharmaceuticals had revenue of 10.09M and earned -130.04M in profits. Earnings per share was -3504.

Revenue Revenue n/a Close	10.09M
Gross Profit Gross Profit n/a Close	2.33M
Operating Income Operating Income n/a Close	-77.74M
Net Income Net Income n/a Close	-130.04M
EBITDA EBITDA n/a Close	-74.94M
EBIT EBIT n/a Close	-75.7M
Earnings Per Share (EPS) Earnings Per Share (EPS) n/a Close	-3504

Full Income Statement

Balance Sheet

The company has 98.78M in cash and 8.12M in debt, giving a net cash position of 90.66M.

Cash & Cash Equivalents Cash & Cash Equivalents n/a Close	98.78M
Total Debt Total Debt n/a Close	8.12M
Net Cash Net Cash n/a Close	90.66M
Retained Earnings Retained Earnings n/a Close	-730.69M
Total Assets Total Assets n/a Close	192.87M
Working Capital Working Capital n/a Close	137.43M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -60.92M and capital expenditures -120K, giving a free cash flow of -61.05M.

Operating Cash Flow Operating Cash Flow n/a Close	-60.92M
Capital Expenditures Capital Expenditures n/a Close	-120K
Free Cash Flow Free Cash Flow n/a Close	-61.05M
FCF Per Share FCF Per Share n/a Close	-26.97

Full Cash Flow Statement

Margins

Gross margin is 23.07%, with operating and profit margins of -770.2% and -1288.25%.

Gross Margin Gross Margin n/a Close	23.07%
Operating Margin Operating Margin n/a Close	-770.2%
Pretax Margin Pretax Margin n/a Close	-1288.25%
Profit Margin Profit Margin n/a Close	-1288.25%
EBITDA Margin EBITDA Margin n/a Close	-742.39%
EBIT Margin EBIT Margin n/a Close	-770.2%
FCF Margin FCF Margin n/a Close	-604.77%

Dividends & Yields

TNXP does not appear to pay any dividends at this time.

Dividend Per Share Dividend Per Share n/a Close	n/a
Dividend Yield Dividend Yield n/a Close	n/a
Dividend Growth (YoY) Dividend Growth (YoY) n/a Close	n/a
Payout Ratio Payout Ratio n/a Close	n/a
Earnings Yield Earnings Yield n/a Close	n/a
FCF Yield FCF Yield n/a Close	n/a

Dividend Details

Analyst Forecast

The average price target for TNXP is $585, which is 1549.3% higher than the current price. The consensus rating is "Strong Buy".

Price Target Price Target n/a Close	$585
Price Target Difference Price Target Difference n/a Close	1549.3%
Analyst Consensus Analyst Consensus n/a Close	Strong Buy
Analyst Count Analyst Count n/a Close	2

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value Lynch Fair Value n/a Close	n/a
Lynch Upside Lynch Upside n/a Close	n/a
Graham Number Graham Number n/a Close	n/a
Graham Upside Graham Upside n/a Close	n/a

Stock Splits

The last stock split was on Feb 5, 2025. It was a backward split with a ratio of 1:100.

Last Split Date Last Split Date n/a Close	Feb 5, 2025
Split Type Split Type n/a Close	backward
Split Ratio Split Ratio n/a Close	1:100

Scores

Altman Z-Score Altman Z-Score n/a Close	9.04
Piotroski F-Score Piotroski F-Score n/a Close	5